MoneyWorks4Me

A decrease of about -34.26% in the sales to Rs. 178.22 millions was observed for the quarter ended March 2025. The sales stood at Rs. 271.08 millions during the similar quarter previous year.A slender decline of -16.06% was recorded to Rs. 24.88  millions from Rs. 29.64 millions in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 36.33 millions from 42.43 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 178.22 271.08 -34.26 665.08 858.31 -22.51 665.08 858.31 -22.51
Other Income 5.75 4.32 33.10 18.39 15.81 16.32 18.39 15.81 16.32
PBIDT 36.33 42.43 -14.38 134.46 140.09 -4.02 134.46 140.09 -4.02
Interest 0.06 1.02 -94.12 0.73 1.81 -59.67 0.73 1.81 -59.67
PBDT 36.27 41.41 -12.41 133.73 138.28 -3.29 133.73 138.28 -3.29
Depreciation 2.27 1.76 28.98 9.05 5.75 57.39 9.05 5.75 57.39
PBT 34.00 39.65 -14.25 124.68 132.53 -5.92 124.68 132.53 -5.92
TAX 9.12 10.01 -8.89 31.94 33.84 -5.61 31.94 33.84 -5.61
Deferred Tax 3.33 3.93 -15.27 6.50 4.39 48.06 6.50 4.39 48.06
PAT 24.88 29.64 -16.06 92.74 98.69 -6.03 92.74 98.69 -6.03
Equity 57.57 57.57 0.00 57.57 57.57 0.00 57.57 57.57 0.00
PBIDTM(%) 20.38 15.65 30.24 20.22 16.32 23.87 20.22 16.32 23.87
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..